P
Pramana
Pramana sets true digital transformation for next-generation pathology
About Pramana
Pramana.ai is a pioneering startup focused on revolutionizing the field of pathology through digital transformation. The company specializes in converting traditional glass pathology slides into digital formats. This digitization process is crucial as it transforms static data into dynamic, valuable knowledge that can significantly enhance diagnostics and personalized medicine for patients.
Pathology, the study of diseases, has relied on physical glass slides for centuries. These slides contain critical information used by pathologists to diagnose diseases. However, managing and analyzing these physical slides can be cumbersome and time-consuming. Pramana.ai addresses this challenge by digitizing these slides, making the data easily accessible and analyzable through advanced software tools.
The primary clients of Pramana.ai include hospitals, diagnostic labs, research institutions, and pharmaceutical companies. These organizations benefit from the company's technology by gaining faster, more accurate diagnostic capabilities and improved data management. The market Pramana.ai operates in is the healthcare and medical diagnostics sector, which is increasingly leaning towards digital solutions to improve efficiency and outcomes.
Pramana.ai's business model revolves around providing digital pathology solutions as a service. They offer a combination of hardware and software solutions to their clients. The company makes money through the sale of its digitization hardware, subscription fees for its software platform, and potentially through data analytics services that offer deeper insights derived from the digitized slides.
In summary, Pramana.ai is at the forefront of digital pathology, offering innovative solutions that transform traditional diagnostic methods. By digitizing pathology slides, they enable faster, more accurate diagnoses and pave the way for personalized medicine.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2021
- Headquarters
- Cambridge, United States
- Employees
- 98
- Open positions
- 2
- Dealroom signal
- 61.3/100
- Industry
- Health
- Sub-industry
- Medical Devices, Health Platform
- Sector
- Health Tech & Medtech, Medical Imaging, Health Diagnostics, AI for medical imaging, Hard Tech, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Aug 2025 | $0 | — | Evident Scientific | ↗ |
| SERIES A✓Equity / VC | Jan 2022 | $30M | $120M | Matrix Capital Management | — |
Growth signals
Latest recorded traffic for Pramana is 13K monthly website visits, up 165.3% over the last three months. Pramana's team declined 1% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Matrix Capital Management
Other known investors1 additional known investor
Evident Scientific
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Pramana on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Pramana’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.